REPLIGEN CORP Stockholders Equity

• REPLIGEN CORP showed an increase of +6.8% in Stockholders Equity from 2024 to 2025.
• This data is from REPLIGEN CORP's annual report (Form 10-K), filed with the SEC on February 26, 2026.
• XBRL data for this metric is available from 2012 to 2025 (14 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Quarterly values from 10-Q filings: Q2 2015: $118.22 million | Q3 2015: $121.45 million | Q1 2016: $128.89 million | Q2 2016: $163.72 million | Q3 2016: $166.52 million | Q1 2017: $176.79 million | Q2 2017: $190.94 million | Q3 2017: $576.87 million | Q1 2018: $597.18 million | Q2 2018: $598.66 million | Q3 2018: $606.49 million | Q1 2019: $625.03 million | Q2 2019: $878.97 million | Q3 2019: $1.05 billion | Q1 2020: $1.07 billion | Q2 2020: $1.10 billion | Q3 2020: $1.12 billion | Q1 2021: $1.56 billion | Q2 2021: $1.60 billion | Q3 2021: $1.72 billion | Q1 2022: $1.77 billion | Q2 2022: $1.81 billion | Q3 2022: $1.84 billion | Q1 2023: $1.94 billion | Q2 2023: $1.96 billion | Q3 2023: $1.97 billion | Q1 2024: $1.97 billion | Q2 2024: $1.98 billion | Q3 2024: $2.02 billion | Q1 2025: $1.99 billion | Q2 2025: $2.06 billion | Q3 2025: $2.08 billion.
• Over the full 14 years of available data (2012 to 2025), REPLIGEN CORP's Stockholders Equity has grown by 2,403.6%.
• Historical annual values: Fiscal year 2025: $2.11 billion | Fiscal year 2024: $1.97 billion | Fiscal year 2023: $1.96 billion | Fiscal year 2022: $1.91 billion | Fiscal year 2021: $1.75 billion | Fiscal year 2020: $1.53 billion | Fiscal year 2019: $1.06 billion | Fiscal year 2018: $615.57 million | Fiscal year 2017: $591.55 million | Fiscal year 2016: $168.76 million | Fiscal year 2015: $122.75 million | Fiscal year 2014: $111.73 million | Fiscal year 2013: $84.12 million | Fiscal year 2012: $84.12 million.
• Data sourced from SEC EDGAR public filings as of August 6, 2026.

Last verified: August 6, 2026